Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.

Greve AM, Bang CN, Berg RM, Egstrup K, Rossebø AB, Boman K, Nienaber CA, Ray S, Gohlke-Baerwolf C, Nielsen OW, Okin PM, Devereux RB, Køber L, Wachtell K.

Int J Cardiol. 2015 Feb 1;180:122-8. doi: 10.1016/j.ijcard.2014.11.181. Epub 2014 Nov 26.

PMID:
25438232
2.

The long and short of the PR-interval: relation to cardiovascular outcome in patients with coronary heart disease.

Bang CN, Okin PM.

Europace. 2014 Oct 26. pii: euu284. [Epub ahead of print] No abstract available.

PMID:
25345829
3.
4.

Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).

Greve AM, Dalsgaard M, Bang CN, Egstrup K, Rossebø AB, Boman K, Cramariuc D, Nienaber CA, Ray S, Gohlke-Baerwolf C, Okin PM, Devereux RB, Køber L, Wachtell K.

Am J Cardiol. 2014 Sep 1;114(5):751-6. doi: 10.1016/j.amjcard.2014.06.006. Epub 2014 Jun 21.

PMID:
25048345
5.

Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.

Bang CN, Greve AM, Køber L, Rossebø AB, Ray S, Boman K, Nienaber CA, Devereux RB, Wachtell K.

Int J Cardiol. 2014 Aug 20;175(3):492-8. doi: 10.1016/j.ijcard.2014.06.013. Epub 2014 Jun 28.

PMID:
25012498
6.

Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.

Greve AM, Dalsgaard M, Bang CN, Egstrup K, Ray S, Boman K, Rossebø AB, Gohlke-Baerwolf C, Devereux RB, Køber L, Wachtell K.

Stroke. 2014 Jul;45(7):1939-46. doi: 10.1161/STROKEAHA.114.005296. Epub 2014 Jun 5.

PMID:
24903982
7.

Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.

Bang CN, Gerdts E, Aurigemma GP, Boman K, de Simone G, Dahlöf B, Køber L, Wachtell K, Devereux RB.

Circ Cardiovasc Imaging. 2014 May;7(3):422-9. doi: 10.1161/CIRCIMAGING.113.001275. Epub 2014 Apr 10.

PMID:
24723582
8.

First-degree atrioventricular block may not be that benign after all.

Bang CN, Okin PM.

J Hypertens. 2014 May;32(5):986-7. doi: 10.1097/HJH.0000000000000164. No abstract available.

PMID:
24695392
9.

Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapy.

Okin PM, Bang CN, Wachtell K, Hille DA, Kjeldsen SE, Julius S, Dahlöf B, Devereux RB.

Am J Hypertens. 2014 Jul;27(7):966-72. doi: 10.1093/ajh/hpu006. Epub 2014 Feb 19.

PMID:
24552888
10.

Statin treatment, new-onset diabetes, and other adverse effects: a systematic review.

Bang CN, Okin PM.

Curr Cardiol Rep. 2014 Mar;16(3):461. doi: 10.1007/s11886-013-0461-4. Review.

PMID:
24464306
11.

New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.

Bang CN, Gislason GH, Greve AM, Bang CA, Lilja A, Torp-Pedersen C, Andersen PK, Køber L, Devereux RB, Wachtell K.

J Am Heart Assoc. 2014 Jan 21;3(1):e000382. doi: 10.1161/JAHA.113.000382.

12.

Psoriasis is associated with subsequent atrial fibrillation in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint study.

Bang CN, Okin PM, Køber L, Wachtell K, Gottlieb AB, Devereux RB.

J Hypertens. 2014 Mar;32(3):667-72. doi: 10.1097/HJH.0000000000000078.

PMID:
24379001
13.

Atrial fibrillation.

Bang CN.

Dan Med J. 2013 Oct;60(10):B4731.

PMID:
24083535
14.

Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.

Bang CN, Gerdts E, Aurigemma GP, Boman K, Dahlöf B, Roman MJ, Køber L, Wachtell K, Devereux RB.

J Hypertens. 2013 Oct;31(10):2060-8. doi: 10.1097/HJH.0b013e328362bbd6. Erratum in: J Hypertens. 2014 Jul;32(7):1548.

PMID:
23838656
15.

Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study.

Bang CN, Dalsgaard M, Greve AM, Køber L, Gohlke-Baerwolf C, Ray S, Rossebø AB, Egstrup K, Wachtell K.

Int J Cardiol. 2013 Oct 3;168(3):2322-7. doi: 10.1016/j.ijcard.2013.01.060. Epub 2013 Feb 14.

PMID:
23416018
16.

Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy.

Okin PM, Bang CN, Wachtell K, Hille DA, Kjeldsen SE, Dahlöf B, Devereux RB.

Circ Arrhythm Electrophysiol. 2013 Apr;6(2):243-51. doi: 10.1161/CIRCEP.112.977777. Epub 2013 Feb 12.

17.

Global systolic load, left ventricular hypertrophy, and atrial fibrillation.

Bang CN, Greve AM, Wachtell K, Kober L.

Am Heart J. 2012 Oct;164(4):e13. doi: 10.1016/j.ahj.2012.07.017. Epub 2012 Sep 20. No abstract available.

PMID:
23067925
18.

Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.

Bang CN, Gislason GH, Greve AM, Torp-Pedersen C, Køber L, Wachtell K.

Eur J Prev Cardiol. 2014 Mar;21(3):330-8. doi: 10.1177/2047487312462804. Epub 2012 Sep 25.

PMID:
23012689
19.

The preventive effect of statin therapy on new-onset and recurrent atrial fibrillation in patients not undergoing invasive cardiac interventions: a systematic review and meta-analysis.

Bang CN, Greve AM, Abdulla J, Køber L, Gislason GH, Wachtell K.

Int J Cardiol. 2013 Aug 10;167(3):624-30. doi: 10.1016/j.ijcard.2012.08.056. Epub 2012 Sep 19. Review.

PMID:
22999824
20.

Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.

Bang CN, Greve AM, Boman K, Egstrup K, Gohlke-Baerwolf C, Køber L, Nienaber CA, Ray S, Rossebø AB, Wachtell K.

Am Heart J. 2012 Apr;163(4):690-6. doi: 10.1016/j.ahj.2012.01.026.

PMID:
22520536
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk